China Universal Asset Management Co., Ltd. - RECURSION PHARMACEUTICALS IN ownership

RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 146 filers reported holding RECURSION PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 2.3%.

Quarter-by-quarter ownership
China Universal Asset Management Co., Ltd. ownership history of RECURSION PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$40
+122.2%
5,237
+116.4%
0.01%
+100.0%
Q2 2023$18
+5.9%
2,420
-2.6%
0.01%0.0%
Q1 2023$17
+21.4%
2,485
+34.6%
0.01%0.0%
Q4 2022$14
-99.9%
1,846
+19.3%
0.01%
-14.3%
Q3 2022$16,0001,5470.01%
Other shareholders
RECURSION PHARMACEUTICALS IN shareholders Q3 2022
NameSharesValueWeighting ↓
CRV, LLC 733,986$16,889,00037.30%
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC 1,388,889$31,958,0005.87%
Yong Rong (HK) Asset Management Ltd 377,000$8,675,0005.69%
Samsara BioCapital, LLC 752,939$17,325,0002.72%
HARVARD MANAGEMENT CO INC 1,509,254$34,728,0002.04%
Spouting Rock Asset Management, LLC 52,851$1,216,0000.61%
PLATINUM INVESTMENT MANAGEMENT LTD 661,703$15,226,0000.43%
Laurion Capital Management LP 3,923,713$90,285,0000.38%
Casdin Capital, LLC 548,156$12,613,0000.31%
Baillie Gifford 22,061,374$507,632,0000.27%
View complete list of RECURSION PHARMACEUTICALS IN shareholders